Plutavimab, CAS [[2529854-88-2]]
Artikelnummer:
MCE-HY-P99104
| Artikelname: |
Plutavimab, CAS [[2529854-88-2]] |
| Artikelnummer: |
MCE-HY-P99104 |
| Hersteller Artikelnummer: |
HY-P99104 |
| Alternativnummer: |
MCE-HY-P99104-25MG,MCE-HY-P99104-10MG,MCE-HY-P99104-1MG,MCE-HY-P99104-5MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Antikörper |
| Alternative Synonym: |
COVI-AMG, STI-2020 |
| Plutavimab a human IgG1-kappa anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD)[1][2]. |
| Molekulargewicht: |
(143.981 kDa) |
| Reinheit: |
98.619 |
| CAS Nummer: |
[2529854-88-2] |
| Target-Kategorie: |
SARS-CoV |
| Anwendungsbeschreibung: |
MCE Product type: Inhibitory Antibodies |
